Is "innovation" in clinical trials just a cover for offshoring risk and cozy politics?
In this episode of **Note to File**, Brad and Denali dive into two big stories shaping clinical research right now:
1. **Congress vs Big Pharma in China**
- US House subcommittee letters to Merck, AbbVie, Lilly, Pfizer & more
- Early-phase trials in **Chinese military hospitals**
- Alleged **informed consent gaps** and **IP leakage** to the Chinese military
- Is this about **ethics & patient safety**, or **America-first politics** and control?
2. **"Real-Time Trials" & the Paradigm Problem**
- What the hell is *"signal-level data"* actually supposed to mean?
- Why the FDA + Paradigm announcement felt like **ready, fire, aim**
- Venture capital, ex-government leadership, Operation Warp Speed ties
- Are we solving real problems, or just funding the best press releases?
Along the way we also hit:
- Work-life balance vs American grind culture (paternity leave, 4‑day work week)
- National "holidays" for everything (Asteroid Day, Social Media Day… Note to File Day when?)
- Clinical trials in **Minecraft** (yes, we went there)
If you care about **where trials are really going**—who controls the data, who sets the rules, and who actually benefits—this one's for you.
👉 **Subscribe** for more unfiltered, independent commentary on clinical trials, sites, and the messy reality behind the headlines.
💬 Got thoughts on China trials or real-time trials? Drop them in the comments or hit us at **NoteToFilePodcast.com**.
